Tsubota Laboratory Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	200	1,357	673	954	640
Revenue Growth (YoY)	-85.26%	101.63%	-29.45%	49.06%	-6.84%
Cost of Revenue	68	180	653	235	84
Gross Profit	132	1,177	20	719	556
Selling, General & Admin	919	663	435	394	276
Research & Development	-	254	205	126	116
Operating Expenses	919	941	670	552	420
Operating Income	-787	236	-650	167	136
Interest Expense	-	-1	-1	-	-1
Interest & Investment Income	3	-	-	-	-
Currency Exchange Gain (Loss)	-	38	-	-6	-
Other Non Operating Income (Expenses)	23	7	14	-17	67
EBT Excluding Unusual Items	-761	280	-637	144	202
Pretax Income	-761	280	-637	144	202
Income Tax Expense	-	75	4	54	49
Net Income	-761	205	-641	90	153
Net Income to Common	-761	205	-641	90	153
Net Income Growth	-	-	-	-41.18%	-23.88%
Shares Outstanding (Basic)	26	26	25	25	23
Shares Outstanding (Diluted)	26	26	25	26	23
Shares Change (YoY)	-0.49%	1.52%	-0.28%	12.97%	0.70%
EPS (Basic)	-29.55	8.01	-25.14	3.66	6.76
EPS (Diluted)	-29.55	7.92	-25.14	3.52	6.76
EPS Growth	-	-	-	-47.93%	-24.41%
Free Cash Flow	-585	-330	-313	-16	582
Free Cash Flow Per Share	-22.71	-12.75	-12.28	-0.63	25.71
Gross Margin	66.00%	86.73%	2.97%	75.37%	86.88%
Operating Margin	-393.50%	17.39%	-96.58%	17.51%	21.25%
Profit Margin	-380.50%	15.11%	-95.25%	9.43%	23.91%
Free Cash Flow Margin	-292.50%	-24.32%	-46.51%	-1.68%	90.94%
EBITDA	-767	264	-615	206	173
EBITDA Margin	-	19.45%	-91.38%	21.59%	27.03%
D&A For EBITDA	20	28	35	39	37
EBIT	-787	236	-650	167	136
EBIT Margin	-	17.39%	-96.58%	17.51%	21.25%
Effective Tax Rate	-	26.79%	-	37.50%	24.26%